| Authors: |
Baiyegunhi OO; Africa Health Research Institute, Durban, South Africa.; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Mthembu K; Africa Health Research Institute, Durban, South Africa., Reuschl A-K; Division of Infection and Immunity, University College London, London, United Kingdom., Ojwach D; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Farinre O; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Maimela M; Africa Health Research Institute, Durban, South Africa., Balinda S; Medical Research Council, UVRI & LSTHM Uganda Research Unit, Entebbe, Uganda., Price M; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.; IAVI, New York, New York, USA., Bunders MJ; Division of Regenerative Medicine and Immunology, III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Ragon Institute of MGH, MIT, and Harvard University, Boston, USA., Altfeld M; Research Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany., Jolly C; Division of Infection and Immunity, University College London, London, United Kingdom., Mann J; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Ndung'u T; Africa Health Research Institute, Durban, South Africa.; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Division of Infection and Immunity, University College London, London, United Kingdom.; Ragon Institute of MGH, MIT, and Harvard University, Boston, USA. |
